Mhairi Skinner

Mhairi Skinner  


Executive Summary

Mhairi Skinner drafts and prosecutes patent applications relating to biotechnology and pharmacology among other technical fields. A patent agent in the Ottawa office of Borden Ladner Gervais LLP, she is a member of the Intellectual Property Group. Mhairi also conducts IP due diligence searches and provides freedom-to-operate opinions.

Following graduate school, Mhairi co-founded a biotechnology company in the area of cancer therapeutics. She has previously worked as an editor at Nature Publishing Group, as a consultant to the National Institute of Health (National Cancer Institute) and as an Adjunct Professor at the University of Guelph. She has conducted research in the areas of biochemistry, cell and molecular biology, bioinformatics, and genetics. Mhairi is fluent in both English and French.

Representative Work

  • Preparing and prosecuting patent applications relating to biotechnology and pharmaceuticals, among other technical fields.
  • Conducting IP due diligence in support of technology transactions.
  • Preparing freedom-to operate opinions with respect to intellectual property matters.

Publications & Presentations

  • Skinner & Marsman, "Protecting your invention: Navigating the waters of inadvertent public disclosures: helpful hints for academic researchers," Canadian Biotechnology Industry Guide, 2012, 24.
  • Skinner, "Non-coding RNA: A new molecular pathway for TP53," Nature Reviews Molecular Cell Biology, 2011, 12, 402-3.
  • Skinner, "Therapy: Drugs hitch a ride," Nature Reviews Drug Discovery, 2010, 9, 434.
  • Skinner, "Stem Cells: Insights into breast cancer heterogeneity," Nature Reviews Cancer, 2010, 10, 163.
  • Bruns, Stegelmann, Skinner et al., "Abl tyrosine kinase controls phagosomal acidification required for killing of mycobacterium tuberculosis in human macrophages," submitted to Journal of Immunology, 2012.
  • Chen, Skinner et al., "The 16kDa subunit of vacuolar H+-ATPase is a novel sarcoglycan-interacting protein," Biochim Biophys Acta, 2007 1772(5) 570-9.
  • Hurtado, Skinner et al., "V-ATPase interacts with ARNO and Arf6 in early endosomes and regulates the protein degradative pathway," Nature Cell Biology, 2006, 8(2): 124-36.
  • Anes, Peyron, Skinner et al., "Dynamic Life and death interactions between mycobacterium smegmatis and J774 macrophages," Cellular Microbiology, 2006, 8(6): 939-60.
  • Skinner & Wildeman, "Suppression of tumor-related glycosylation of cell surface receptors by the 16 kDa membrane subunit of the vacuolar H+-ATPase," Journal of Biological Chemistry, 2001, 276(51) 48451-7.
  • Skinner & Wildeman, "Beta 1 integrin binds the 16 kDa subunit of the vacuolar H(+)ATPase at a site important for human papillomavirus E5 and platelet-derived growth factor signalling," Journal of Biological Chemistry, 1999 274(33) 23119-27.